In a study from the DILIN study group in the US, six patients with TNF-alpha inhibitors induced liver injury and additional 28 patients from the literature were analyzed: infliximab (n = 26), etanercept (n = 4) and adalimumab (n = 4) (Ghabril et al., 2013). The gene discussed is TNF; the disease is injury.